Effect of Breast-Conserving Therapy versus Radical Mastectomy on Prognosis for Young Women with Breast Carcinoma

Cancer

Volumn 100, Issue 4, 2004, Pages 688-693

  Kroman, Niels ^a,b,c   Holtveg, Helle ^d   Wohlfahrt, Jan ^a   Jensen, Maj Britt ^b   Mouridsen, Henning T ^b   Blichert Toft, Mogens ^c   Melbye, Mads ^a,e  

^a STATENS SERUM INSTITUT   (Denmark)

^b Danish Breast Cancer Cooperative Group   (Denmark)

^c Rigshospitalet   (Denmark)

^d Hoersholm Hospital   (Denmark)

^e KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Breast carcinoma; Breast conserving therapy; Radical mastectomy; Surgical treatment; Young age

Indexed keywords

CYCLOPHOSPHAMIDE; EPIRUBICIN; FLUOROURACIL; METHOTREXATE;

ADULT; ARTICLE; BREAST CARCINOMA; CANCER RECURRENCE; CANCER SURVIVAL; DENMARK; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MASTECTOMY; PREMENOPAUSE; PRIORITY JOURNAL; PROGNOSIS; SURGICAL TECHNIQUE;

ADULT; AGE FACTORS; BREAST NEOPLASMS; CARCINOMA; COHORT STUDIES; DENMARK; FEMALE; HUMANS; MASTECTOMY, RADICAL; MASTECTOMY, SEGMENTAL; NEOPLASM RECURRENCE, LOCAL; PREMENOPAUSE; PROGNOSIS; REGISTRIES; RISK FACTORS; SURVIVAL ANALYSIS;

EID: 0842282689     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/cncr.20022     Document Type: Article

References (31)

1. Fisher B, Anderson S, Bryant J, et al. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med. 2002;347:1233-1241.
2. Veronesi U, Cascinelli N, Mariani L, et al. Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. N Engl J Med. 2002;347:1227-1232.
3. Fisher B, Anderson S, Fisher ER, et al. Significance of ipsilateral breast tumour recurrence after lumpectomy. Lancet. 1991;338:327-331.
4. Harrold EV, Turner BC, Matloff ET, et al. Local recurrence in the conservatively treated breast cancer patient: a correlation with age and family history. Cancer J Sci Am. 1998;4:302-307.
5. Elkhuizen PH, Voogd AC, van den Broek LC, et al. Risk factors for local recurrence after breast-conserving therapy for invasive carcinomas: a case-control study of histological factors and alterations in oncogene expression. Int J Radiat Oncol Biol Phys. 1999;45:73-83.
6. Mirza NQ, Vlastos G, Meric F, et al. Predictors of locoregional recurrence among patients with early-stage breast cancer treated with breast-conserving therapy. Ann Surg Oncol. 2002;9:256-265.
7. Touboul E, Buffat L, Belkacemi Y, et al. Local recurrences and distant metastases after breast-conserving surgery and radiation therapy for early breast cancer. Int J Radiat Oncol Biol Phys. 1999;43:25-38.
8. Voogd AC, Nielsen M, Peterse JL, et al. Differences in risk factors for local and distant recurrence after breast-conserving therapy or mastectomy for Stage I and II breast cancer: pooled results of two large European randomized trials. J Clin Oncol. 2001;19:1688-1697.
9. Hellman S. Karnofsky Memorial Lecture. Natural history of small breast cancers. J Clin Oncol. 1994;12:2229-2234.
10. Early Breast Cancer Trialists' Collaborative Group. Favourable and unfavourable effects on long-term survival of radiotherapy for early breast cancer: an overview of the randomised trials. Lancet. 2000;355:1757-1770.
11. Overgaard M, Hansen PS, Overgaard J, et al. Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. Danish Breast Cancer Cooperative Group 82b Trial. N Engl J Med. 1997;337:949-955.
12. Overgaard M, Jensen MB, Overgaard J, et al. Postoperative radiotherapy in high-risk postmenopausal breast cancer patients given adjuvant tamoxifen: Danish Breast Cancer Cooperative Group DBCG 82c randomised trial. Lancet. 1999;353:1641-1648.
13. Koscielny S, Tubiana M. Link between local recurrence and distant metastases in human breast cancer. Int J Radiat Oncol Biol Phys. 1999;45:245-246.
14. Rouzier R, Extra JM, Carton M, et al. Primary chemotherapy for operable breast cancer: incidence and prognostic significance of ipsilateral breast tumor recurrence after breast-conserving surgery. J Clin Oncol. 2001;19:3828-3835.
15. Vrieling C, Collette L, Fourquet A, et al. Can patient-, treatment- and pathology-related characteristics explain the high local recurrence rate following breast-conserving therapy in young patients? Eur J Cancer. 2003;39:932-944.
16. Dalberg K, Mattsson A, Sandelin K, Rutqvist LE. Outcome of treatment for ipsilateral breast tumor recurrence in early-stage breast cancer. Breast Cancer Res Treat. 1998;49:69-78.
17. Kroman N, Jensen MB, Wohlfahrt J, Mouridsen HT, Andersen PK, Melbye M. Factors influencing the effect of age on prognosis in breast cancer: population based study. Br Med J. 2000;320:474-479.
18. Andersen KW, Mouridsen HT. Danish Breast Cancer Cooperative Group (DBCG). A description of the register of the nation-wide programme for primary breast cancer. Acta Oncol. 1988;27:627-647.
19. Storm HH. The Danish Cancer Registry, a self-reporting national cancer registration system with elements of active data collection. IARC Sci Publ. 1991;95:220-236.
20. Rostgaard K, Holst H, Mouridsen HT, Lynge E. Do clinical databases render population-based cancer registers obsolete? The example of breast cancer in Denmark. Cancer Causes Control. 2000;11:669-674.
21. Melbye M, Wohlfahrt J, Olsen JH, et al. Induced abortion and the risk of breast cancer. N Engl J Med. 1997;336:81-85.
22. Danmarks Statistik. Statistical ten-year review. Copenhagen: Danmarks Statistik, 1996.
23. al Saati T, Clamens S, Cohen-Knafo E, et al. Production of monoclonal antibodies to human estrogen-receptor protein (ER) using recombinant ER (RER). Int J Cancer. 1993;55:651-654.
24. Adami HO, Malker B, Holmberg L, Persson I, Stone B. The relation between survival and age at diagnosis in breast cancer. N Engl J Med. 1986;315:559-563.
25. Chung M, Chang HR, Bland KI, Wanebo HJ. Younger women with breast carcinoma have a poorer prognosis than older women. Cancer. 1996;77:97-103.
26. Winchester DP, Osteen RT, Menck HR. The National Cancer Data Base report on breast carcinoma characteristics and outcome in relation to age. Cancer. 1996;78:1838-1843.
27. Albain KS, Allred DC, Clark GM. Breast cancer outcome and predictors of outcome: are there age differentials? J Natl Cancer Inst Monogr. 1994;16:35-42.
28. Remvikos Y, Magdelenat H, Dutrillaux B. Genetic evolution of breast cancers. III. Age-dependent variations in the correlations between biological indicators of prognosis. Breast Cancer Res Treat. 1995;34:25-33.
29. Walker RA, Lees E, Webb MB, Dearing SJ. Breast carcinomas occurring in young women (< 35 years) are different. Br J Cancer. 1996;74:1796-1800.
30. Blichert-Toft M, Rose C, Andersen JA, et al. Danish randomized trial comparing breast conservation therapy with mastectomy: six years of life-table analysis. Danish Breast Cancer Cooperative Group. J Natl Cancer Inst Monogr. 1992;11:19-25.
31. Goldhirsch A, Glick JH, Gelber RD, Coates AS, Senn HJ. Meeting highlights: International Consensus Panel on the Treatment of Primary Breast Cancer. Seventh International Conference on Adjuvant Therapy of Primary Breast Cancer. J Clin Oncol. 2001;19:3817-3827.